Your session is about to expire
← Back to Search
Extended Work Schedules, Sleep Loss and Health (EW and EWD Trial)
N/A
Waitlist Available
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This study aims to determine whether abnormal bodily rhythms contribute to elevate the risk of diabetes, independently of the amount of sleep loss.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Sleep loss and circadian misalignmentExperimental Treatment1 Intervention
Group II: Sleep loss and circadian alignmentExperimental Treatment1 Intervention
Sleep restriction without circadian misalignment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fixed restricted bedtimes
2003
N/A
~50
Sleep restriction with circadian misalignment
2003
N/A
~50
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
840,337 Total Patients Enrolled
14 Trials studying Sleep
1,459 Patients Enrolled for Sleep